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METHODS
Cloning: A polymerase chain reaction (PCR) is then performed using sequence specific primers and Dreamtaq master
mix. The PCR products are then visualized on an agarose gel. If the PCR is successful, then the PCR amplicons and
undergo an overnight digest with restriction enzymes. The vector (PUT18C and pKT25) were cut using the same
restriction sites. After digestion, the DNA is concentrated and cleaned with Zymo Clean and Concentrate kit. This
concentrates the PCR products and purifies it from any contaminants/nucleotides/primers/enzymes. This product is then
run on a final agarose gel before ligation. A ligation is then performed, which inserts the potential interacting partner
DNA sequence into the corresponding vector.
Bacterial transformation: For the cloning transformation, DH5α cells are used. The entire ligation mixture is put into
the competent cell preparation, heat shocked at 42◦C, mixed with 750µL of SOC media, and incubated in shaker for 1
hour at 37◦C. The transformation is then plated onto LB agar plates with 100 ng/mL ampicillin and grown overnight at
37◦C.
For the Bacterial-two hybrid, DHM1 or BTH101 competent cells are used for transformation. The same heat shock
transformation method as DH5α is used. The final constructs in the PKT25 series (prey) and PUT18C series (bait) (one
bait and one prey) are both transformed into the same bacterial strain.
ABSTRACT
Chlamydia trachomatis is an obligate intracellular bacterial pathogen which poses
severe health problems throughout the world. There are over 90 million new cases
annually, making it the most common sexually transmitted disease in the world.
Chlamydia can pose significant problems during and after infection. It is imperative to
understand how Chlamydia manipulates the host cell and potentially develop future
treatments. The mechanisms by which C. trachomatis alters immune response is not
well understood, but recent work has identified an interaction between the chlamydial
inclusion membrane protein, CT226, and the potential interacting host proteins,
Flightless homologue II (FLII), Leucine Rich-Repeat Flightless-Interacting Proteins
1&2 (LRRFIP1 and LRRFIP2) and TMOD3. FLII, LRRFIP1 and LRRFIP2 are
known to interact as a complex and are upstream regulators of the inflammasome.
Currently, it is unknown if CT226 interacts with one or all of the interacting partners
and needs the actual interaction needs investigation. My hypothesis is that CT226 will
directly interact with one of the 3 potential interacting partners (LRRFIP1, LRRFIP2,
and FLII) and that we will be able to detect this interaction in the bacterial two hybrid
system. Current efforts have focused on cloning CT226 into PUT18 and the three host
proteins (FLII, LRRFIP1 and LRRFIP2) individually into PKNT25. PUT18 and
PKNT25 are the bait and prey plasmids that have been adapted for use in the bacterial
two hybrid system. Once each pair of plasmids are properly transformed (each E. coli
strain will have two plasmids, one carrying CT226 and one carrying the potential
interacting partner), they will be screened using traditional β-galactosidase assays or






Chlamydia trachomatis is an obligate intracellular bacterial pathogen which poses 
severe health problems throughout the world. There are over 90 million new cases 
annually, making it the most common sexually transmitted disease in the world (1). 
Specific interactions between C. trachomatis and the host cell are important for survival 
due to its reduced genome (2). Chlamydia can pose significant problems during and 
after infection. It is imperative to understand how Chlamydia manipulates the host cell 
to obtain a better understanding of the pathogen and potentially develop future 
treatments. When Chlamydia first infects a cell, it does so as an elementary body (EB) 
which converts into a reticulate body (RB) during the replicative phase and then slowly 
transitions back to the EB infectious form at the end of the life cycle before infecting 
neighboring cells. The mechanisms by which C. trachomatis alters immune response is 
not well understood, but recent work done by my lab and other labs (3) have identified 
an interaction between the chlamydial inclusion membrane protein, CT226, and the 
potential interacting host proteins, Flightless homologue II (FLII), and Leucine Rich-
Repeat Flightless-Interacting Proteins 1&2 (LRRFIP1 and LRRFIP2) and TMOD3. 
These three proteins (FLII, LRRFIP,1 and LRRFIP2) are known to work as a complex 
and are also known to interact with each other. My hypothesis is that CT226 will 
directly interact with one of the 3 potential interacting partners (LRRFIP1, LRRFIP2, 
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Figure 1. Schematic 
representation of CT226 
interaction with TOMD3,  



















Figure 2. Cloning of Genes for Bacterial 
Two Hybrid System. A) Schematic 
representation of regions of genes cloned 
into the bacterial-two hybrid plasmids. TM= 
transmembrane domain B) PCR 
amplification of target genes.
Figure 3. Mechanism of Bacterial-Hybrid interaction. When two proteins interact, 
cAMP is generated which interacts with CAP complex initiating transcription of target 
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• CT226, TMOD3 and FL2 have successfully been cloned 
into the bacterial two hybrid
• LRRFIP1 are currently in the process of being cloned
• Cloning of LRRFIP2 will commence after cDNA clone 
has been obtained
• Once the final constructs are finished, we will assay for 
interactions between CT226, TMOD3, LRRFIP1 and 
FLII in the bacterial-two hybrid with growth on maltose 
and β-galactosidase expression
